FIGMA, INC. (FIG) Spending and interest coverage
- R&D / revenue · 12 months: Value 94.97%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 130.57%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 94.97% | Research and development expense / revenue. Period ending 2026-06-30. $1.22B ÷ $1.28B × 100 ≈ 94.97% |
| Stock-based compensation / revenue · 12 months | 130.57% | Share-based compensation / revenue. Period ending 2026-06-30. $1.67B ÷ $1.28B × 100 ≈ 130.57% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 1.22B USD | Research and Development Expense |
| Revenue | 1.28B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 1.67B USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -1.59B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.22B | $1.28B | $1.67B | $-1.59B | (m) | 94.97% | 130.57% | (m) | (m) |
| 2026-03-31 | $1.13B | $1.16B | $1.53B | $-1.47B | (m) | 97.56% | 132.03% | (m) | (m) |
| 2025-12-31 | $1.03B | $1.06B | $1.36B | $-1.29B | (m) | 97.53% | 129.21% | (m) | (m) |
| 2025-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $751.12M | $749.01M | $947.55M | $-877.43M | (m) | 100.28% | 126.51% | (m) | (m) |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $164.77M | $504.87M | $2.70M | $-73.46M | (m) | 32.64% | 0.54% | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.